Yeasts have a tradition in biotechnological applications, and Saccharomyces species are
the most dominating representatives. Among the yeast species, Candida krusei has been …

Although Candida albicans remains the main cause of candidiasis, in recent years a
significant number of infections has been attributed to non-albicans Candida (NAC) species …

Early reports of Candida krusei in man describe the organism as a transient, infrequent
isolate of minor clinical significance inhabiting the mucosal surfaces. More recently it has …

Fungal infections represent a constant and growing menace to human health, because of
the emergence of new species as causative agents of diseases and the increment of …

Candida krusei is an emerging pathogen that is well known for its propensity to develop
resistance to fluconazole and other azoles. Despite the potential clinical significance of C …

Although Candida albicans is the most common human yeast pathogen, other Candida
species such as C. krusei are now recognized as emerging agents, especially in patients …

Candida glabrata is mostly good, but, at times, it is an opportunistic pathogen. Previously
known as Torulopsis glabrata, it enjoyed a good reputation and was even present in starter …

Yeasts of the Candida genus comprise a group of microbes with a significant potential for
industrial use. This work presents some directions for biotechnological use of these …

Atypical Candida spp. infections are rising, mostly due to the increasing numbers of
immunocompromised patients. The most common Candida spp. is still Candida albicans; …

Candida krusei is a notable pathogenic fungus that causes invasive candidiasis, mainly due
to its natural resistance to fluconazole. However, to date, there is limited research on the …